Effectiveness, Flexibility and Safety of Switching IVF to IVM as a Rescue Strategy in Unexpected Poor Ovarian Response for PCOS Infertility Patients
Open Access
- 2 March 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 1978
Abstract
Background: According to the latest practice committee document, in vitro maturation (IVM) is a simple and safe procedure, especially in patients with polycystic ovary syndrome (PCOS). Does switching from in vitro fertilization (IVF) to IVM (IVF/M) help as a rescue infertility treatment for PCOS patients with an unexpected poor ovarian response (UPOR) tendency? Methods: This retrospective cohort study included 531 women with PCOS who had undergone 588 natural IVM cycles or had switched to IVF/M cycles from 2008 to 2017. Natural IVM was performed in 377 cycles, and switching IVF/M was performed in 211 cycles. The primary outcome measure was the cumulative live birth rates (cLBRs), and the secondary outcomes included laboratory and clinical outcomes, maternal safety, and obstetric and perinatal complications. Results: No significant difference was found in the cLBRs between the natural IVM and switching IVF/M groups (23.6% vs. 17.4%, p = 0.05). Meanwhile, the natural IVM group had a higher cumulative clinical pregnancy rate (36.0% vs. 26.0%, p = 0.01), and a decrease in the number of oocytes was obtained in the switching IVF/M group (13.5 vs. 12.0, p < 0.01). The number of good quality embryos in the natural IVM group was 2.2 ± 2.5, and 2.1 ± 2.3 (p = 0.64) in the switching IVF/M group. No statistically significant differences were observed in the number of 2 pronuclear (2PN) and available embryos. Ovarian hyperstimulation syndrome (OHSS) did not occur in the switching IVF/M and natural IVM groups, indicating a highly favorable outcome. Conclusion: In PCOS infertile women with UPOR, timely switching IVF/M is a viable option that markedly reduces the canceled cycle, results in reasonable oocyte retrieval, and leads to live births.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (2019-I2M-5-001, 81730038, Z191100006619073)
- National Natural Science Foundation of China (2019-I2M-5-001, 81730038, Z191100006619073)
- Beijing Municipal Science & Technology Commission (2019-I2M-5-001, 81730038, Z191100006619073)
This publication has 33 references indexed in Scilit:
- The Bologna criteria for poor ovarian response: a contemporary critical appraisalJournal of Ovarian Research, 2015
- Assessing ovarian response: antral follicle count versus anti-Müllerian hormoneReproductive BioMedicine Online, 2015
- Prevalence of polycystic ovary syndrome in women in China: a large community-based studyHuman Reproduction, 2013
- In vitro maturation: a committee opinionFertility and Sterility, 2013
- Conversion of ICSI cycles to IUI in poor responders to controlled ovarian hyperstimulationMiddle East Fertility Society Journal, 2012
- Annulations en fécondation in vitro : mauvais pronostic, mauvaises répondeuses, ou variabilité de la réponse à la stimulation ? Analyse de 142 annulationsJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2011
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteriaHuman Reproduction, 2011
- The Istanbul consensus workshop on embryo assessment: proceedings of an expert meetingHuman Reproduction, 2011
- Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatmentFertility and Sterility, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004